HF patients in Africa and Asia see opportunities for improvement in health insurance rates and beta blocker usage compared to other regions.
The study highlights significant regional disparities in heart failure etiologies, treatments, and socioeconomic factors across multiple continents, emphasizing the need for improved beta-blocker utilization and insurance coverage in Africa and Asia.
Absolute Event Rate: 0% vs 0%
INTER-CHF describes significant regional variability in socioeconomic and clinical factors, etiologies and treatments in HF patients from Africa, Asia, the Middle East and South America. Opportunities exist for improvement in health/medication insurance rates and proportions of patients on beta blockers, particularly in Africa and Asia.
Dokainish et al. (Wed,) reported a other. HF patients in Africa and Asia see opportunities for improvement in health insurance rates and beta blocker usage compared to other regions.